Article
21 Oct 2024
New DEA Rule Expected To Extend Controlled Substance Telemedicine Prescribing Flexibilities Through 2025
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
13 May 2024
50-State Survey Of Telehealth Insurance Laws
Article
13 Dec 2023
2024 Predictions: Unveiling The Future Of Healthcare Mergers And Acquisitions
Article
22 Nov 2023
Current Look At Digital Health
Article
13 Nov 2023
Top 5 Rules For Medicare 2024 Remote Patient Monitoring And Remote Therapeutic Monitoring: What Companies Need To Know
Article
22 May 2023
DEA Extends Telemedicine Flexibilities For Prescribing Of Controlled Medications
Article
12 Apr 2023
Foley & Lardner Comment Letter On DEA Telemedicine Controlled Substance Proposed Rule
Article
02 Mar 2023
DEA's Proposed Rules On Telemedicine Controlled Substances Prescribing After The PHE Ends
Article
13 Jan 2023
2023 Forecast For Digital Health Startups And Telemedicine Law
Article
27 Dec 2022
The Future Of Telemedicine Post-PHE And How To Advocate For Change: An Interview With Nathaniel Lacktman